Posted on 6/19/18
Matinas BioPharma Prices $8.0 Million Public Offering
BEDMINSTER, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines . . .
Posted on 6/19/18
Verrica Pharmaceuticals Closes IPO
WEST CHESTER, Pa., June 19, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for . . .
Posted on 6/19/18
Neuronetics Readies $75 Million IPO
Neuronetics (STIM) intends to sell shares of its common stock for gross proceeds of $75 million from a U.S. IPO, according to an S-1/A registration statement.
Posted on 6/19/18
Here's Why PTC Therapeutics Is Soaring While Biogen and Ionis Struggle
What happenedShares of PTC Therapeutics (NASDAQ:PTCT) are up 24.6% at 12:40 p.m. EDT after PTC and partner Roche (NASDAQOTH:RHHBY) presented data on their spinal muscular atrophy . . .
Posted on 6/18/18
ContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates
EDISON, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the . . .
Posted on 6/18/18
New Study Finds Reusable Bronchoscopes Contaminated and Damaged Even When Proper Cleaning and Disinfection Steps are Taken
Using Single-Use Bronchoscopes Could Significantly Reduce the Risk of Life-threatening Infection Transmission Among PatientsBronchoscopy is one of the most common interventional pulmonology procedures and most practitioners . . .
Posted on 6/18/18
Champions Oncology Partners with Puma Biotechnology and NSABP Foundation
Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced . . .
Posted on 6/18/18
Should You Buy Celgene Stock?
A trial failure, disappointing long-term guidance, and an embarrassing stumble at the FDA's finish line have erased billions of dollars from Celgene Corp.'s (NASDAQ:CELG) market cap . . .
Posted on 6/18/18
Better Buy: Pfizer Inc. vs. Johnson & Johnson
The two biggest U.S.-based drugmakers are household names. Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) have been in business since the 19th century. Both big pharma . . .
Posted on 6/18/18
Better Buy: Johnson & Johnson vs. Eli Lilly
Investors couldn't go wrong choosing between Johnson & Johnson (NYSE:JNJ) and Eli Lilly and Co. (NYSE:LLY) a decade ago. Over the past 10 years, the big . . .
Posted on 6/18/18
Ortho Clinical Diagnostics Named Transatlantic Legal Department of the Year by Panel of Leading Legal Journalists
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that its in-house Legal and Compliance Department has been named the Transatlantic Legal . . .
Posted on 6/17/18
Immunomedics Closes Public Offering of Common Stock
MORRIS PLAINS, N.J., June 15, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced the . . .
Posted on 6/17/18
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
RADNOR, Pa., June 15, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to . . .
Posted on 6/15/18
Finger-Pointing At Celgene
Just what is going on at Celgene (NASDAQ:CELG)? They've had some odd recent setbacks (such as the failure of Mongersen), and another such acquisition, Ozanimod, had . . .
Posted on 6/14/18
Verrica Pharmaceuticals Goes Public
WEST CHESTER, Pa., June 14, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for . . .
Posted on 6/14/18
CitiusTech Named to Healthcare Informatics Top 100 List for Third Consecutive Year
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology services and solutions, has been ranked 75th in the 2018 Healthcare Informatics (HCI) 100 list. Every year . . .
Posted on 6/14/18
Immunomedics: Short-Term Risk, Long-Term Opportunity
Immunomedics (NASDAQ:IMMU) is a clinical-stage biotech pharmaceutical company specializing in cancer therapies. A market cap near $4.2 billion shows a tremendous amount of optimism about the . . .
Posted on 6/14/18
Recent Purchase: Johnson & Johnson
With Johnson & Johnson (JNJ) recently hitting 52-week lows and falling to the 3% yield threshold, there has been a lot of buzz around the stock . . .
Posted on 6/14/18
Northwest Bancshares (NWBI) Acquisition Of Donegal Financial Services Corporation - Slideshow
The following slide deck was published by Northwest Bancshares, Inc. in conjunction with this event. 116READ FULL ARTICLE HERE
Posted on 6/13/18
Johnson & Johnson: Recent Price Drop Offers Opportunity
I have written about Johnson & Johnson (JNJ) several times in the past, but since the last article was around 8 months ago, I think an . . .
Posted on 6/13/18
Immunomedics Announces Pricing of Public Offering of Common Stock
MORRIS PLAINS, N.J., June 13, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced the . . .
Posted on 6/13/18
Johnson & Johnson Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript)
Thank you everyone for joining us. I'm really pleased to have members of JNJ Research Team our final team. So a little bit different this time, . . .
Posted on 6/13/18
Can This Pharma's $14 Billion Bet Succeed?
A couple of years back, Pfizer Inc. (NYSE:PFE) took a lot of heat in order to pull off a massive $14 billion acquisition that added Xtandi . . .
Posted on 6/12/18
Hu-manity.co And Orb Health Partner
PRINCETON, N.J.--(BUSINESS WIRE)--Hu-manity.co, a company designed to create decentralized human rights using proprietary technology and legal innovations on blockchains, has partnered with Orb Health, a leading . . .
Posted on 6/12/18
Better Buy: Verizon Communications Inc. vs. Johnson & Johnson
It can be hard to evaluate companies in different industries, but investors who seek out diversified portfolios often face the challenge of choosing from high-quality stocks . . .

